TY  - CONF 
AU  - Vázquez Estévez, Sergio
PY  - 2015
SN  - 0959-8049
UR  - http://hdl.handle.net/20.500.11940/6020
LA  - eng
TI  - Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the international metastatic renal-cell carcinoma database consortium prognostic model (IMRCC). The SPAZO study (SOGUG)
VL  - 51
ER  -